Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 552 (ZNF552) is a human protein encoded by the ZNF552 gene, located on chromosome 19q13.43. It is a member of the Kruppel-associated box (KRAB) subfamily of C2H2-type zinc finger proteins, featuring an amino-terminal KRAB domain and seven carboxyl-terminal C2H2 zinc finger motifs. ZNF552 acts as a transcriptional repressor and inhibits the activity of transcription factors such as AP-1 and SRE, likely through its KRAB domain. The protein is primarily nuclear but also localizes to the cytoplasm in human tissues, with highest expression observed in the lung and testis. While it is predicted to play a role in gene expression regulation, ZNF552 is not currently recognized as a therapeutic target, and no direct disease associations, interacting drugs, or clinical biomarker applications are established.
Not applicable (no drugs targeting ZNF552; general mechanism is repression of AP-1 and SRE transcriptional activity via its KRAB domain if experimentally manipulated)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 552 (ZNF552).